ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO.,LTD. Financials Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
Equities
300452
CNE100001ZH5
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.96 CNY | +6.24% |
|
+2.87% | -1.97% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 3,916 | 4,071 | 3,308 | 3,243 | - |
| Enterprise Value (EV) 1 | 3,916 | 4,071 | 3,308 | 3,243 | 3,243 |
| P/E ratio | 44.7 x | 31.3 x | 21.3 x | 17.5 x | 14.7 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 5.78 x | 3.94 x | 3.35 x | 2.89 x |
| EV / Revenue | - | 5.78 x | 3.94 x | 3.35 x | 2.89 x |
| EV / EBITDA | - | 23.6 x | 14.7 x | 11.7 x | 9.68 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | 5.69 x | 4.02 x | 3.39 x | 2.87 x |
| Nbr of stocks (in thousands) | 2,32,471 | 2,32,387 | 2,32,324 | 2,32,304 | - |
| Reference price 2 | 16.85 | 17.52 | 14.24 | 13.96 | 13.96 |
| Announcement Date | 22/04/22 | 07/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 704.5 | 839.3 | 967 | 1,122 |
| EBITDA 1 | - | 172.5 | 224.5 | 277 | 335 |
| EBIT 1 | - | 136.3 | 185.4 | 213 | 253 |
| Operating Margin | - | 19.34% | 22.1% | 22.03% | 22.55% |
| Earnings before Tax (EBT) 1 | - | 136.4 | 185.8 | 213 | 253 |
| Net income 1 | 89.25 | 130.7 | 161.5 | 187 | 222 |
| Net margin | - | 18.55% | 19.25% | 19.34% | 19.79% |
| EPS 2 | 0.3769 | 0.5600 | 0.6700 | 0.8000 | 0.9500 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 22/04/22 | 07/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 19.4% | 20.5% | 19.3% | 19.5% |
| ROA (Net income/ Total Assets) | - | 12.2% | - | 10.5% | 11% |
| Assets 1 | - | 1,072 | - | 1,781 | 2,018 |
| Book Value Per Share 2 | - | 3.080 | 3.540 | 4.120 | 4.870 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | 66.6 | 54.8 | 198 | 188 |
| Capex / Sales | - | 9.46% | 6.53% | 20.48% | 16.76% |
| Announcement Date | 22/04/22 | 07/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.96
CNY
Average target price
18
CNY
Spread / Average Target
+28.94%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.97% | 423M | |
| +32.36% | 709B | |
| +30.77% | 595B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B |
- Stock Market
- Equities
- 300452 Stock
- Financials Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.